NCT02658968 2024-01-16Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)Nordic NanovectorPhase 1 Completed18 enrolled 16 charts
NCT02657447 2019-01-10Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)Nordic NanovectorPhase 1 Withdrawn
NCT00002327 2005-06-24The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected PatientsNIH AIDS Clinical Trials Information ServicePhase 1 Completed40 enrolled